MiMedx Group (MDXG) Reaches $15.36 High on Jun, 19; Auburn National Bancorp (AUBN) SI Increased By 125%

June 19, 2017 - By Louis Casey

The stock of MiMedx Group Inc (NASDAQ:MDXG) reached all time high today, Jun, 19 and still has $15.82 target or 3.00% above today’s $15.36 share price. This indicates more upside for the $1.72B company. This technical setup was reported by Barchart.com. If the $15.82 PT is reached, the company will be worth $51.60M more. About 486,126 shares traded. MiMedx Group Inc (NASDAQ:MDXG) has risen 107.87% since June 19, 2016 and is uptrending. It has outperformed by 91.17% the S&P500.

Auburn National Bancorp Incorporated (NASDAQ:AUBN) had an increase of 125% in short interest. AUBN’s SI was 900 shares in June as released by FINRA. Its up 125% from 400 shares previously. With 2,700 avg volume, 0 days are for Auburn National Bancorp Incorporated (NASDAQ:AUBN)’s short sellers to cover AUBN’s short positions. The SI to Auburn National Bancorp Incorporated’s float is 0.04%. About 178 shares traded. Auburn National Bancorporation Inc (NASDAQ:AUBN) has risen 26.06% since June 19, 2016 and is uptrending. It has outperformed by 9.36% the S&P500.

Analysts await MiMedx Group Inc (NASDAQ:MDXG) to report earnings on July, 25.

MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The company has market cap of $1.72 billion. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. It has a 114.94 P/E ratio. The Company’s biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix.

Among 7 analysts covering MiMedx Group (NASDAQ:MDXG), 5 have Buy rating, 2 Sell and 0 Hold. Therefore 71% are positive. MiMedx Group had 10 analyst reports since July 29, 2015 according to SRatingsIntel. Needham downgraded it to “Buy” rating and $15 target in Wednesday, July 29 report. The firm earned “Buy” rating on Friday, December 18 by Canaccord Genuity. On Wednesday, January 20 the stock rating was maintained by First Analysis with “Overweight”. The firm has “Strong Buy” rating given on Monday, November 16 by Needham. The stock has “Sell” rating by UBS on Monday, December 12. The rating was maintained by Needham on Wednesday, October 14 with “Buy”. Lake Street maintained the shares of MDXG in report on Tuesday, April 19 with “Buy” rating. The stock has “Outperform” rating by Northland Capital on Friday, October 30. As per Tuesday, May 23, the company rating was downgraded by First Analysis. Aegis Capital initiated the stock with “Buy” rating in Tuesday, November 8 report.

Since March 6, 2017, it had 0 buys, and 4 selling transactions for $2.17 million activity. Taylor William Charles also sold $1.16 million worth of MiMedx Group Inc (NASDAQ:MDXG) on Wednesday, June 14. $429,136 worth of MiMedx Group Inc (NASDAQ:MDXG) was sold by KOOB CHARLES E on Monday, March 13.

Investors sentiment increased to 1.22 in 2016 Q4. Its up 0.07, from 1.15 in 2016Q3. It improved, as 16 investors sold MiMedx Group Inc shares while 47 reduced holdings. 23 funds opened positions while 54 raised stakes. 54.88 million shares or 0.33% more from 54.70 million shares in 2016Q3 were reported. Clearbridge Limited Company has invested 0.02% in MiMedx Group Inc (NASDAQ:MDXG). Victory Cap Mngmt holds 12,664 shares. Envestnet Asset Mngmt invested 0% of its portfolio in MiMedx Group Inc (NASDAQ:MDXG). Moreover, Smith Howard Wealth Management Ltd Llc has 0.08% invested in MiMedx Group Inc (NASDAQ:MDXG) for 17,361 shares. Capstone Asset Mgmt Co invested 0.01% in MiMedx Group Inc (NASDAQ:MDXG). Amer International Grp, New York-based fund reported 74,692 shares. Rice Hall James & Limited Liability Co holds 0.14% in MiMedx Group Inc (NASDAQ:MDXG) or 324,325 shares. First Allied Advisory holds 0% or 10,464 shares. Summit Creek stated it has 1.4% in MiMedx Group Inc (NASDAQ:MDXG). Sei Co reported 926 shares. Ferguson Wellman Mngmt invested in 20,420 shares. Raymond James Assoc reported 0% in MiMedx Group Inc (NASDAQ:MDXG). Moreover, Thompson has 0.68% invested in MiMedx Group Inc (NASDAQ:MDXG) for 390,995 shares. Dimensional Fund Advisors Limited Partnership owns 0% invested in MiMedx Group Inc (NASDAQ:MDXG) for 51,071 shares. 407 are owned by Us National Bank De.

Investors sentiment decreased to 0.86 in Q4 2016. Its down 0.64, from 1.5 in 2016Q3. It dived, as 3 investors sold Auburn National Bancorporation Inc shares while 4 reduced holdings. 3 funds opened positions while 3 raised stakes. 213,281 shares or 15.34% less from 251,922 shares in 2016Q3 were reported. Blackrock Fund holds 0% or 595 shares. Stevens First Principles Inv, California-based fund reported 1,000 shares. Bancorp Of America De holds 600 shares or 0% of its portfolio. Lincoln National reported 16,055 shares. 526 are held by Oakworth Cap. Alliancebernstein L P stated it has 0% in Auburn National Bancorporation Inc (NASDAQ:AUBN). 393 were accumulated by Blackrock Mgmt. Royal Natl Bank Of Canada owns 0% invested in Auburn National Bancorporation Inc (NASDAQ:AUBN) for 200 shares. Illinois-based Banc Funds Co Ltd Liability Com has invested 0.15% in Auburn National Bancorporation Inc (NASDAQ:AUBN). Mufg Americas Holding accumulated 64 shares or 0% of the stock. Next Grp has invested 0% of its portfolio in Auburn National Bancorporation Inc (NASDAQ:AUBN). Dimensional Fund Advsr L P has 0% invested in Auburn National Bancorporation Inc (NASDAQ:AUBN). Suntrust Banks Incorporated reported 0.01% stake. Wells Fargo And Mn stated it has 0% of its portfolio in Auburn National Bancorporation Inc (NASDAQ:AUBN).

Auburn National Bancorporation, Inc

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>